Overview

Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Dermatitis eczematous is a recurrent pruritic skin disorder which has a significant morbidity and impaired quality of life due specially pruritus and physical visible skin lesions. The purpose of this trial is evaluate the effectiveness of two different topic associations of drugs.
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Benzocaine
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Gentamicins
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Polymyxin B
Polymyxins
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate